CenterWatch

Cushing's Disease Clinical Trials

A listing of Cushing's Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Alabama

UPDATED

Birmingham Alabama 35294

A Phase 2 clinical study for patients with Cushing's Disease

Arizona

Peoria Arizona 85381

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

California

Los Angeles California 90095

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

San Diego California 92108

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Torrance California 90502

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Illinois

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Maryland

Johns Hopkins University School of Medicine Division of Endocrinology, Diabetes & Metabolism
Baltimore Maryland 21287

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Michigan

University of Michigan Medical Center Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Ann Arbor Michigan 48109

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Ann Arbor Michigan 48109-0944

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Nebraska

Omaha Nebraska 68131

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

New Mexico

University of New Mexico HSC
Albuquerque New Mexico 87131

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

New York

Icahn School of Medicine at Mount Sinai
New York New York 10029

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

New York New York 10032

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

New York New York 10029

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Ohio

Cleveland Clinic Endocrinology
Cleveland Ohio 44195

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

CarePoint East
Columbus Ohio 43203

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Oregon

Oregon Health & Science University
Portland Oregon

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

UPDATED

Portland Oregon 97239

A Phase 2 clinical study for patients with Cushing's Disease

Portland Oregon 97239

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Pennsylvania

University of Pennslyvania Smilow Center for Translational Research
Philadelphia Pennsylvania 19104-5160

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Pittsburgh Pennsylvania 15212

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Tennessee

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Wisconsin

Milwaukee Wisconsin 53226

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Belgium

UZLeuven Dienst endocrinologie
Leuven International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

France

Endocrinologie, Pavillon des Ecrins Centre Hospitalier Universitaire, Hopital Nord
Cedex International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Hôpital de la TIMONE Department of Endocrinology and Reference Center for Rare Pituitary Diseases
Marseille International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Centre de Réference Maladies Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Paris International 75014

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Israel

Institute of Endocrinology & Metabolism Rabin Medical Center, Beilinson Campus
Petah Tiqva International 49100

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Netherlands

Erasmus MC, Dpt. Of Internal Medicine, Division of Endocrinology Centre Hospitalier Universitaire, Hopital Nord
Rotterdam International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Spain

Hospital Universitario de la Ribera Centre Hospitalier Universitaire, Hopital Nord
Alzira-Valencia International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Hospital Sant Pau, Universitat Autònoma de Barcelona
Barcelona International 08025

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Argentina

UPDATED

Caba Buenos Aires C1280AEB

A Phase 2 clinical study for patients with Cushing's Disease

Australia

UPDATED

Darlinghurst New South Wales 2010

A Phase 2 clinical study for patients with Cushing's Disease

UPDATED

Woolloongabba Queensland 4102

A Phase 2 clinical study for patients with Cushing's Disease

Belgium

UPDATED

Gent 9000

A Phase 2 clinical study for patients with Cushing's Disease

UPDATED

Leuven 3000

A Phase 2 clinical study for patients with Cushing's Disease

Brazil

UPDATED

Porto Alegre RS 90560-030

A Phase 2 clinical study for patients with Cushing's Disease

Bulgaria

UPDATED

Sofia 1431

A Phase 2 clinical study for patients with Cushing's Disease

Colombia

UPDATED

Bogotá Cundinamarca 110111

A Phase 2 clinical study for patients with Cushing's Disease

France

UPDATED

Bron Cedex 69677

A Phase 2 clinical study for patients with Cushing's Disease

UPDATED

Marseille cedex 05 13385

A Phase 2 clinical study for patients with Cushing's Disease

UPDATED

Pessac Cedex 33604

A Phase 2 clinical study for patients with Cushing's Disease

UPDATED

Vandoeuvre Cedex 54511

A Phase 2 clinical study for patients with Cushing's Disease

Germany

UPDATED

Erlangen 91054

A Phase 2 clinical study for patients with Cushing's Disease

UPDATED

Essen 45147

A Phase 2 clinical study for patients with Cushing's Disease

UPDATED

Frankfurt 60590

A Phase 2 clinical study for patients with Cushing's Disease